To determine whether the prognostic model can apply to other clinical factors, stratification analysis was performed according to age, sex, tumor site, pathological T stage, pathological N stage, MMR status, TP53 mutation status, KRAS mutation status, and BRAF mutation status. Here, TP53 is linked to neoplasm.